BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32072405)

  • 1. MiR-501-5p acts as an energetic regulator in head and neck squamous cell carcinoma cells growth and aggressiveness via reducing CLCA4.
    Li B; Jiang YP; Zhu J; Meng L
    Mol Biol Rep; 2020 Mar; 47(3):2181-2187. PubMed ID: 32072405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of
    Tanaka N; Minemura C; Asai S; Kikkawa N; Kinoshita T; Oshima S; Koma A; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-18a-5p Facilitates Malignant Progression of Head and Neck Squamous Cell Carcinoma Cells via Modulating SORBS2.
    Chen Q; Xu J; Zhu M
    Comput Math Methods Med; 2021; 2021():5953881. PubMed ID: 34707683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
    Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
    Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of long non-coding RNA LINC00958 inhibits head and neck squamous cell carcinoma progression and AKT/mTOR signaling pathway by targeting miR-106a-5p.
    Yang YF; Feng L; Shi Q; Wang LW; Hou LZ; Wang R; Fang JG
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8408-8417. PubMed ID: 32894548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma.
    Li J; Chen W; Luo L; Liao L; Deng X; Wang Y
    Aging (Albany NY); 2020 Nov; 13(1):769-781. PubMed ID: 33257597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Tumor Suppressive Genes Regulated by
    Oshima S; Asai S; Seki N; Minemura C; Kinoshita T; Goto Y; Kikkawa N; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Oncogenic Targets by Tumor-Suppressive
    Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
    Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00467 enhances head and neck squamous cell carcinoma progression and the epithelial-mesenchymal transition process via miR-299-5p/ubiquitin specific protease-48 axis.
    Chen Y; Ding Y
    J Gene Med; 2020 Jul; 22(7):e3184. PubMed ID: 32159247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
    Huang Q; Shen YJ; Hsueh CY; Guo Y; Zhang YF; Li JY; Zhou L
    BMC Cancer; 2021 Oct; 21(1):1074. PubMed ID: 34598688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-34a-5p functions as a tumor suppressor in head and neck squamous cell cancer progression by targeting Flotillin-2.
    Li X; Zhao S; Fu Y; Zhang P; Zhang Z; Cheng J; Liu L; Jiang H
    Int J Biol Sci; 2021; 17(15):4327-4339. PubMed ID: 34803501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
    Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
    Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma.
    Zhuang Z; Yu P; Xie N; Wu Y; Liu H; Zhang M; Tao Y; Wang W; Yin H; Zou B; Hou J; Liu X; Li J; Huang H; Wang C
    Theranostics; 2020; 10(3):1433-1453. PubMed ID: 31938073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis.
    Shen M; Zhou Z; Li BB; Lv M; Feng C; Chen S; Shi S; Kang M; Zhao T
    Technol Cancer Res Treat; 2022; 21():15330338221081245. PubMed ID: 35235474
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.
    Saleh AD; Cheng H; Martin SE; Si H; Ormanoglu P; Carlson S; Clavijo PE; Yang X; Das R; Cornelius S; Couper J; Chepeha D; Danilova L; Harris TM; Prystowsky MB; Childs GJ; Smith RV; Robertson AG; Jones SJM; Cherniack AD; Kim SS; Rait A; Pirollo KF; Chang EH; Chen Z; Van Waes C
    Clin Cancer Res; 2019 May; 25(9):2860-2873. PubMed ID: 30723145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.